The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review
H.M. Bruins(Radboud University Nijmegen), J. Alfred Witjes(Radboud University Nijmegen), Philip Dahm, Thomas Lam(University of Aberdeen), Fiona Stewart(University of Aberdeen), Thierry Lebrét(Université de Versailles Saint-Quentin-en-Yvelines), Amir Sherif(Umeå University), Erik Veskimäe(Tampere University), Antoine G. van der Heijden(Radboud University Nijmegen), Éva Compérat(Vienna General Hospital), Nigel C. Cowan(Queen Alexandra Hospital), Maria De Santis(Medical University of Vienna), Virginia Hernández(Hospital Universitario Fundación Alcorcón), Georgios Gakis(University Hospital in Halle), Molly M. Neuberger(University of Florida), María J. Ribal(Hospital Clínic de Barcelona), James N’Dow(University of Aberdeen), Mari Imamura(University of Aberdeen)
Cited by 213
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694